| Literature DB >> 22295154 |
Xiangning Qiu1, Guiying Zhang, Rong Xiao, Jing Zhang, Ying Zhou, Ganqun Li, Kailin Yan, Qianjin Lu.
Abstract
The development of factor VIII inhibitors in non-hemophilic patients is rare and may occur in healthy individuals, mostly elderly and women in postpartum period, and in patients with malignant neoplasia or autoimmune diseases, such as bullous pemphigoid. We described the case of a 60-year-old female patient who developed bullous pemphigoid for 3 month and presented with bleeding tendency and hematoma in the tongue. Therapy with methylprednisolone, cyclophosphamide, intravenous immunoglobulin and factor VIII reposition was instituted, resulting in a remission of the bleeding and negativity for antibodies against factor VIII titers. We concluded that, despite its rarity, the presence of acquired factor VIII inhibitors should be investigated when patients with autoimmune diseases develop bleeding manifestations.Entities:
Keywords: Bullous pemphigoid; acquired hemophilia; factor VIII inhibitor
Mesh:
Substances:
Year: 2012 PMID: 22295154 PMCID: PMC3267493
Source DB: PubMed Journal: Int J Clin Exp Pathol ISSN: 1936-2625